Survival and Factors Predictive of Survival in Patients with Thymic Carcinoma
Siriraj Medical Journal · 01.10.2026 · 71 (6) · 472-479
DOI: 10.33192/smj.2019.70 ↗Kurz gefasst
Fachartikel in der Zeitschrift Siriraj Medical Journal, online erschienen am 01.10.2026. Verfasst von Suparauk Geanphun und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
A corrigendum has been published for this article. Please see the corrigendum here: https://doi.org/10.33192/smj.v78i10.285017 Objective: Thymic carcinoma is a rare malignancy that has a poor prognosis and low 5-year survival. The rarity of this disease and the variety of histologic subtypes has limited the evidence needed to establish disease-specific staging and treatment guidelines. The aim of this study was to investigate overall survival, the factors that predict survival, and the treatment modalities that influence survival in patients with thymic carcinoma.
Methods
All thymic carcinoma cases diagnosed and treated at Siriraj Hospital (Bangkok, Thailand) during 1997-2013 were retrospectively reviewed. Univariate and multivariate analyses were performed to identify factors that predict survival, and overall survival was estimated by Kaplan-Meier method.
Results
Of the 45 patients diagnosed during the study period, 8 were lost to follow-up. The remaining 37 patients were included in our analysis. The median survival time was 2.5 years, with 5-year and 10-year survival of 40% and 16%, respectively. In univariate analysis, tumors >10 cm (p=0.017), high-grade histologic subtypes (p=0.014), and high Masaoka stage (p=0.011) were significant determinants of survival. Multivariate analysis revealed tumor size (HR: 3.594, 95% CI: 1.103-11.714; p=0.034) and high-grade histologic subtypes (HR: 8.175, 95% CI: 1.689-39.566; p=0.009) to be independent predictors of survival. Patients who underwent tumor removal had significantly longer median survival time than those who didn’t (3.85 vs. 0.63 years; p=0.005).
Conclusion
Thymic carcinoma patients have low 5-year and 10-year survival. Tumor size and high-grade histologic subtype were identified as independent predictors of survival, and surgical therapy was found to be significantly associated with longer median survival time.
Zitieren
APA
Geanphun, S., & Sakiyalak, P. (2026). Survival and Factors Predictive of Survival in Patients with Thymic Carcinoma. Siriraj Medical Journal, 71(6), 472-479. https://doi.org/10.33192/smj.2019.70
Vancouver
Geanphun S, Sakiyalak P. Survival and Factors Predictive of Survival in Patients with Thymic Carcinoma. Siriraj Medical Journal. 2026;71(6):472-479. doi:10.33192/smj.2019.70
BibTeX
@article{Geanphun2026,
author = {Geanphun, Suparauk and Sakiyalak, Pranya},
title = {Survival and Factors Predictive of Survival in Patients with Thymic Carcinoma},
journal = {Siriraj Medical Journal},
year = {2026},
volume = {71},
number = {6},
pages = {472--479},
doi = {10.33192/smj.2019.70}
}
EUVIMED